WPI 3969 (Metronidazole 250 mg)
Pill imprint WPI 3969 has been identified as Metronidazole 250 mg.
Metronidazole is used in the treatment of bacterial vaginitis; std prophylaxis; bacterial infection; dental abscess; giardiasis (and more), and belongs to the drug classes amebicides, miscellaneous antibiotics. There is no proven risk in humans during pregnancy. Metronidazole 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WPI 3969
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Amebicides
Miscellaneous antibiotics - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 00591-3969
More about metronidazole
Consumer resources
- Metronidazole
- Metronidazole capsules
- Metronidazole extended-release tablets
- Metronidazole tablets
- Metronidazole Intravenous (Advanced Reading)
- Metronidazole Oral, Intravenous (Advanced Reading)
- Other brands: Flagyl, Metro, Flagyl ER, Flagyl 375, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
